Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
16.05. | HHS, DARPA link up with Rutgers, Cost Plus Drugs and others in initiative to rethink US drug production | ||
16.05. | After 19 months, FDA lifts clinical hold on vaginal yeast infection drug Brexafemme | ||
16.05. | With marketing chief's departure, Omnicom Health loses another exec ahead of Interpublic merger | ||
16.05. | WuXi Biologics slims down again, handing off German plant to CDMO Terumo for $167M | ||
16.05. | Incyte's Zynyz secures approvals in anal cancer 4 years after FDA rejection | ||
16.05. | Novo to part ways with longtime CEO Lars Fruergaard Joergensen, citing weight of market pressures | ||
15.05. | Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit | ||
15.05. | GSK sponsors Lifetime movie for meningitis B vaccine awareness, with help from 'Buffy' stars | ||
15.05. | Merck KGaA cites Trump tariffs, funding cuts as it scales back 2025 contracting forecast | ||
15.05. | Novartis, Sarepta tipped to drive genomic therapy sales toward $90B | ||
15.05. | Riding its Peloton buyout, Merck rolls to third FDA nod for potential blockbuster Welireg | ||
15.05. | Merck's Keytruda finds a path in ovarian cancer with phase 3 win in certain patients | ||
14.05. | AbbVie advances solid tumor agenda with FDA nod for lung cancer ADC Emrelis | ||
14.05. | Sanofi hops on the US investment bandwagon with $20B commitment through 2030 | ||
14.05. | Genentech pays tribute to moms of children with hemophilia A in Hemlibra short film | ||
14.05. | Roche to reconsider US investment projects if Trump follows through on pricing order | ||
14.05. | Apellis' weak quarter for Syfovre signals uphill climb for geographic atrophy med: analyst | ||
14.05. | AbbVie plant workers in Ireland threaten to strike over pay dispute: reports | ||
14.05. | Bluebird bio investor reluctance pays off as Carlyle, SK improve buyout offer by 67% | ||
14.05. | CDMO Famar expands reach in Europe with acquisition of sterile manufacturing plant in Germany | ||
13.05. | Organon taps into 'romantasy' craze with new Nexplanon ad | ||
13.05. | As Bayer's restructuring rolls on, Kerendia and Nubeqa power pharma unit to surprising sales increase | ||
13.05. | Roche spotlights Perjeta's staying power with 10-year breast cancer survival results | ||
13.05. | Ratio inks deal to build radiopharmaceutical R&D, manufacturing facility in Utah | ||
13.05. | Mayne hit by misleading drug safety claims from the FDA ahead of $430M buyout |